DMU-212

DMU-212 is a modulator of ERK used in studies of MAPK / ERK Signaling and Apoptosis and related signaling programs. In practice, this places the compound in experiments that measure mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and caspase-associated cell-death signaling and survival decisions in apoptosis, cancer, and cell signaling models.

By modulating ERK, DMU-212 can be used to examine mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and caspase-associated cell-death signaling and survival decisions. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving ERK
• Pathway perturbation studies connected to MAPK / ERK Signaling and Apoptosis and related signaling programs
• Context-dependent response profiling and mechanism comparison
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, DMU-212 is appropriate when a defined chemical perturbant is needed to connect ERK with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.